In the presence of 10 nM concentrations of free α−/β-synuclein (Fig. 10e) and α−/γ synuclein (Fig. 10g) significant differences in the percentage of inhibition were observed in plasma from controls and PD patients vs. MSA patients, whereas no difference was found between PD patients and control individuals. This evidence concerns the gene SNCA and Parkinson disease.